| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902238 | 1 | 0.699 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.667 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.512 | |
| renin angiotensin regulation of aldosterone production | GO:0002018 | 3 | 0.499 | |
| sterol esterification | GO:0034434 | 3 | 0.401 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress | GO:0008627 | 2 | 0.355 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902239 | 1 | 0.341 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.293 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.280 | |
| amine metabolic process | GO:0009308 | 45 | 0.273 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902218 | 1 | 0.260 | |
| negative regulation of smooth muscle cell apoptotic process | GO:0034392 | 1 | 0.252 | |
| negative regulation of heart rate | GO:0010459 | 4 | 0.235 | |
| phospholipase c activating angiotensin activated signaling pathway | GO:0086097 | 1 | 0.234 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.234 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.226 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.209 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902219 | 1 | 0.203 | |
| angiotensin activated signaling pathway | GO:0038166 | 4 | 0.201 | |
| activation of janus kinase activity | GO:0042976 | 2 | 0.198 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.193 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.189 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.179 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.177 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.177 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.174 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.172 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.166 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.156 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.156 | |
| regulation of ph | GO:0006885 | 26 | 0.149 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.146 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.143 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.143 | |
| cellular response to osmotic stress | GO:0071470 | 7 | 0.127 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.118 | |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 15 | 0.117 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.116 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.110 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.109 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.109 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.109 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.107 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.107 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.105 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.105 | |
| cation homeostasis | GO:0055080 | 212 | 0.105 | |
| cholesterol esterification | GO:0034435 | 3 | 0.101 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.100 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.100 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.099 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.098 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.097 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.097 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.096 | |
| cellular homeostasis | GO:0019725 | 240 | 0.095 | |
| cellular response to lipid | GO:0071396 | 145 | 0.093 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.092 | |
| negative regulation of peptidyl serine phosphorylation | GO:0033137 | 10 | 0.089 | |
| regulation of response to osmotic stress | GO:0047484 | 3 | 0.089 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.087 | |
| regulation of superoxide anion generation | GO:0032928 | 4 | 0.086 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.086 | |
| regulation of system process | GO:0044057 | 200 | 0.085 | |
| protein secretion | GO:0009306 | 111 | 0.084 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.084 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.083 | |
| t cell migration | GO:0072678 | 19 | 0.077 | |
| oxidation reduction process | GO:0055114 | 342 | 0.075 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.073 | |
| leukocyte migration | GO:0050900 | 124 | 0.072 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.069 | |
| regulation of systemic arterial blood pressure by circulatory renin angiotensin | GO:0001991 | 13 | 0.067 | |
| vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | GO:0002033 | 2 | 0.066 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.066 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.064 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.064 | |
| transmembrane transport | GO:0055085 | 412 | 0.064 | |
| receptor recycling | GO:0001881 | 11 | 0.064 | |
| lipid modification | GO:0030258 | 65 | 0.063 | |
| regulation of cholesterol esterification | GO:0010872 | 2 | 0.061 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.061 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.061 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.061 | |
| regulation of protein transport | GO:0051223 | 163 | 0.060 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.059 | |
| cell chemotaxis | GO:0060326 | 81 | 0.059 | |
| steroid esterification | GO:0034433 | 3 | 0.058 | |
| regulation of protein localization | GO:0032880 | 231 | 0.058 | |
| regulation of secretion | GO:0051046 | 274 | 0.057 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.057 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.056 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.056 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.056 | |
| g protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger | GO:0007199 | 1 | 0.054 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.054 | |
| negative regulation of intrinsic apoptotic signaling pathway | GO:2001243 | 34 | 0.054 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.053 | |
| positive regulation of monooxygenase activity | GO:0032770 | 2 | 0.053 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.052 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.051 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.051 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.051 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.050 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.050 | |
| regulation of tube size | GO:0035150 | 57 | 0.049 | |
| cation transport | GO:0006812 | 399 | 0.049 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.048 | |
| vasodilation | GO:0042311 | 28 | 0.048 | |
| cytokine production | GO:0001816 | 319 | 0.048 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.047 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.047 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.047 | |
| regulation of heart rate | GO:0002027 | 36 | 0.046 | |
| chemotaxis | GO:0006935 | 247 | 0.044 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.044 | |
| cytokine secretion | GO:0050663 | 72 | 0.043 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.042 | |
| organic anion transport | GO:0015711 | 137 | 0.042 | |
| superoxide anion generation | GO:0042554 | 11 | 0.042 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.042 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.042 | |
| negative regulation of blood pressure | GO:0045776 | 22 | 0.041 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.041 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.041 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.040 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.040 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.040 | |
| regulation of kidney size | GO:0035564 | 3 | 0.039 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.039 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.038 | |
| neurological system process involved in regulation of systemic arterial blood pressure | GO:0001976 | 18 | 0.038 | |
| metanephros development | GO:0001656 | 79 | 0.037 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.037 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.036 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.036 | |
| intracellular protein transport | GO:0006886 | 204 | 0.035 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.035 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.034 | |
| inflammatory response | GO:0006954 | 244 | 0.034 | |
| calcium ion transport | GO:0006816 | 159 | 0.034 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.034 | |
| negative regulation of blood circulation | GO:1903523 | 15 | 0.033 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.033 | |
| positive regulation of metanephric glomerulus development | GO:0072300 | 4 | 0.033 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.032 | |
| positive regulation of phospholipase activity | GO:0010518 | 3 | 0.032 | |
| response to osmotic stress | GO:0006970 | 21 | 0.032 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.031 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.031 | |
| cell adhesion | GO:0007155 | 329 | 0.031 | |
| muscle cell apoptotic process | GO:0010657 | 18 | 0.030 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.030 | |
| protein localization to organelle | GO:0033365 | 185 | 0.030 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.030 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.030 | |
| renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure | GO:0001999 | 6 | 0.030 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.029 | |
| immune effector process | GO:0002252 | 321 | 0.029 | |
| heart contraction | GO:0060047 | 93 | 0.029 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.027 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.026 | |
| regulation of muscle cell apoptotic process | GO:0010660 | 17 | 0.026 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.026 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.026 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.026 | |
| regulation of intrinsic apoptotic signaling pathway by p53 class mediator | GO:1902253 | 13 | 0.026 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.026 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.026 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.026 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.025 | |
| regulation of receptor recycling | GO:0001919 | 8 | 0.025 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.025 | |
| dopamine metabolic process | GO:0042417 | 23 | 0.025 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.025 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.025 | |
| drinking behavior | GO:0042756 | 5 | 0.025 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.025 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.025 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.024 | |
| glomerulus development | GO:0032835 | 40 | 0.024 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.024 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.024 | |
| phenol containing compound biosynthetic process | GO:0046189 | 21 | 0.024 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.024 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.024 | |
| positive regulation of cholesterol esterification | GO:0010873 | 1 | 0.024 | |
| renal system development | GO:0072001 | 225 | 0.023 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.023 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.023 | |
| lymphocyte migration | GO:0072676 | 26 | 0.023 | |
| angiogenesis | GO:0001525 | 201 | 0.023 | |
| regulation of glomerulus development | GO:0090192 | 6 | 0.023 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.022 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.022 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.022 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.022 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.022 | |
| mapk cascade | GO:0000165 | 281 | 0.022 | |
| heart process | GO:0003015 | 94 | 0.022 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.022 | |
| regulation of cell activation | GO:0050865 | 289 | 0.022 | |
| blood circulation | GO:0008015 | 195 | 0.022 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.022 | |
| membrane organization | GO:0061024 | 245 | 0.022 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.021 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.021 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.021 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.021 | |
| organelle assembly | GO:0070925 | 177 | 0.021 | |
| dna metabolic process | GO:0006259 | 303 | 0.021 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.021 | |
| regulation of oxidoreductase activity | GO:0051341 | 15 | 0.021 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.021 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.021 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.021 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.021 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.021 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.021 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.020 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.020 | |
| protein targeting | GO:0006605 | 143 | 0.020 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.020 | |
| adaptive immune response | GO:0002250 | 155 | 0.020 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.020 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.020 | |
| organic acid transport | GO:0015849 | 101 | 0.020 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.020 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.020 | |
| locomotory behavior | GO:0007626 | 195 | 0.020 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.019 | |
| urogenital system development | GO:0001655 | 261 | 0.019 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.019 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.019 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.019 | |
| lysosome organization | GO:0007040 | 21 | 0.019 | |
| negative regulation of heart contraction | GO:0045822 | 11 | 0.019 | |
| innate immune response | GO:0045087 | 157 | 0.019 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.019 | |
| regulation of lipase activity | GO:0060191 | 15 | 0.019 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.018 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.018 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.018 | |
| endomembrane system organization | GO:0010256 | 147 | 0.018 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.018 | |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | GO:0003072 | 5 | 0.018 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.018 | |
| lytic vacuole organization | GO:0080171 | 21 | 0.018 | |
| circulatory system process | GO:0003013 | 197 | 0.018 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.018 | |
| regulation of superoxide metabolic process | GO:0090322 | 8 | 0.018 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 26 | 0.018 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.018 | |
| feeding behavior | GO:0007631 | 62 | 0.018 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.018 | |
| renal system process | GO:0003014 | 48 | 0.018 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.017 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.017 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.017 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.017 | |
| muscle contraction | GO:0006936 | 101 | 0.017 | |
| regulation of cell migration | GO:0030334 | 219 | 0.017 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.017 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.017 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.017 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.017 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.017 | |
| nuclear transport | GO:0051169 | 139 | 0.017 | |
| regulation of defense response | GO:0031347 | 233 | 0.017 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.017 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.017 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.017 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.017 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.017 | |
| chromatin organization | GO:0006325 | 206 | 0.017 | |
| glucose homeostasis | GO:0042593 | 128 | 0.017 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.017 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.017 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.017 | |
| immunoglobulin production | GO:0002377 | 73 | 0.017 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.017 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.017 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.016 | |
| protein ubiquitination | GO:0016567 | 171 | 0.016 | |
| sensory perception | GO:0007600 | 245 | 0.016 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.016 | |
| protein catabolic process | GO:0030163 | 221 | 0.016 | |
| regulation of jak stat cascade | GO:0046425 | 34 | 0.016 | |
| regulation of blood volume by renin angiotensin | GO:0002016 | 7 | 0.016 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.016 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.016 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.016 | |
| lipid transport | GO:0006869 | 98 | 0.016 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.016 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.016 | |
| maintenance of location | GO:0051235 | 89 | 0.016 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.016 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.016 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.016 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.016 | |
| ossification | GO:0001503 | 216 | 0.016 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.016 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.015 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.015 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.015 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.015 | |
| chromatin modification | GO:0016568 | 187 | 0.015 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.015 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.015 | |
| regulation of nitric oxide synthase activity | GO:0050999 | 6 | 0.015 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.015 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.015 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.015 | |
| tissue migration | GO:0090130 | 68 | 0.015 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.015 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.015 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.015 | |
| kidney development | GO:0001822 | 213 | 0.015 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.015 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.015 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.015 | |
| positive regulation of metanephros development | GO:0072216 | 9 | 0.015 | |
| cellular response to ketone | GO:1901655 | 12 | 0.014 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.014 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.014 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.014 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.014 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.014 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.014 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.014 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.014 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.014 | |
| response to growth factor | GO:0070848 | 198 | 0.014 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.014 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.014 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.014 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.014 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.014 | |
| muscle tissue development | GO:0060537 | 308 | 0.014 | |
| response to estrogen | GO:0043627 | 24 | 0.014 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.014 | |
| neuronal action potential | GO:0019228 | 54 | 0.014 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.014 | |
| activation of nf kappab inducing kinase activity | GO:0007250 | 4 | 0.014 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.014 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.014 | |
| protein import into nucleus | GO:0006606 | 95 | 0.013 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.013 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.013 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.013 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.013 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.013 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.013 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.013 | |
| jak stat cascade | GO:0007259 | 42 | 0.013 | |
| peptide metabolic process | GO:0006518 | 46 | 0.013 | |
| cellular response to alcohol | GO:0097306 | 23 | 0.013 | |
| exploration behavior | GO:0035640 | 21 | 0.013 | |
| hexose metabolic process | GO:0019318 | 98 | 0.013 | |
| regulation of circadian sleep wake cycle sleep | GO:0045187 | 3 | 0.013 | |
| cellularization | GO:0007349 | 1 | 0.013 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.013 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.013 | |
| cell growth | GO:0016049 | 130 | 0.013 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.013 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.013 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.013 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.012 | |
| gtp catabolic process | GO:0006184 | 143 | 0.012 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.012 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.012 | |
| steroid metabolic process | GO:0008202 | 119 | 0.012 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.012 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.012 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.012 | |
| camera type eye development | GO:0043010 | 266 | 0.012 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.012 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.012 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.012 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.012 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.012 | |
| regulation of vasoconstriction | GO:0019229 | 14 | 0.012 | |
| protein oligomerization | GO:0051259 | 67 | 0.012 | |
| male sex differentiation | GO:0046661 | 109 | 0.012 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.012 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.012 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.012 | |
| rhythmic process | GO:0048511 | 174 | 0.012 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.012 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.012 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.012 | |
| kidney epithelium development | GO:0072073 | 121 | 0.012 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.012 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.012 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.012 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.012 | |
| fertilization | GO:0009566 | 127 | 0.012 | |
| renin secretion into blood stream | GO:0002001 | 5 | 0.012 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.012 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.012 | |
| nephron development | GO:0072006 | 109 | 0.012 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.011 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.011 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.011 | |
| defecation | GO:0030421 | 1 | 0.011 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.011 | |
| protein glycosylation | GO:0006486 | 55 | 0.011 | |
| endocytosis | GO:0006897 | 168 | 0.011 | |
| developmental maturation | GO:0021700 | 193 | 0.011 | |
| mesonephros development | GO:0001823 | 97 | 0.011 | |
| exocytosis | GO:0006887 | 121 | 0.011 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.011 | |
| skin development | GO:0043588 | 220 | 0.011 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.011 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.011 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.011 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.011 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.011 | |
| myosin filament assembly | GO:0031034 | 2 | 0.011 | |
| response to nutrient levels | GO:0031667 | 109 | 0.011 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.011 | |
| brain renin angiotensin system | GO:0002035 | 5 | 0.011 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.011 | |
| organelle localization | GO:0051640 | 179 | 0.011 | |
| response to inorganic substance | GO:0010035 | 96 | 0.011 | |
| action potential | GO:0001508 | 78 | 0.011 | |
| regulation of ossification | GO:0030278 | 112 | 0.011 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.011 | |
| positive regulation of nitric oxide synthase activity | GO:0051000 | 2 | 0.011 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.011 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.011 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.011 | |
| lipid localization | GO:0010876 | 126 | 0.011 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.011 | |
| plasma membrane organization | GO:0007009 | 90 | 0.011 | |
| nuclear import | GO:0051170 | 95 | 0.011 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.011 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.011 | |
| vasoconstriction | GO:0042310 | 27 | 0.011 | |
| anion transport | GO:0006820 | 177 | 0.011 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.011 | |
| cellular response to glucocorticoid stimulus | GO:0071385 | 13 | 0.011 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.011 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.011 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.011 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.010 | |
| protein maturation | GO:0051604 | 176 | 0.010 | |
| response to radiation | GO:0009314 | 165 | 0.010 | |
| regulation of ion transport | GO:0043269 | 215 | 0.010 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.010 | |
| sulfur compound biosynthetic process | GO:0044272 | 37 | 0.010 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.010 | |
| glycosylation | GO:0070085 | 62 | 0.010 | |
| protein localization to membrane | GO:0072657 | 108 | 0.010 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.010 | |
| protein processing | GO:0016485 | 163 | 0.010 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.010 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.010 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.010 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.010 | |
| response to dexamethasone | GO:0071548 | 8 | 0.010 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.010 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.010 | |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.010 | |
| defense response to bacterium | GO:0042742 | 119 | 0.010 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.010 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.010 | |
| positive regulation of jak stat cascade | GO:0046427 | 22 | 0.010 | |
| positive regulation of interleukin 8 production | GO:0032757 | 2 | 0.010 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.010 | |
